Dr. Owonikoko is involved in advancing novel therapeutic strategies for the treatment of thoracic malignancies combined with a strong commitment to clinical oncology translational research.
Titles and Roles
- Professor and Vice-Chair for Faculty Development, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Co-Leader, Discovery & Developmental Therapeutics Program
- Winship Cancer Institute of Emory University
- Research Program
- Discovery and Developmental Therapeutics
Taofeek Owonikoko, MD, PhD, MSCR, is a Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A board certified medical oncologist, Dr. Owonikoko specializes in the treatment of lung cancer, thyroid cancer and other cancers of the aerodigestive tract.
Dr. Owonikoko serves as Co-Leader of the Discovery & Developmental Therapeutics research program at Winship Cancer Institute. He also serves as Chair of the Lung and Aerodigestive Malignancies Working Group.
Dr. Owonikoko will hold a Designated Medical Oncologist seat on the American Society of Clinical Oncology's Board of Directors for the term starting in June 2021. He is Co-Chair of the Head and Neck Working Group for the Radiation Research Program in the NCI/CTEP Division of Cancer Treatment and Diagnosis.
Dr. Owonikoko received his Medical Degree from Obafemi Awolowo University, Ile-Ife Nigeria in 1991. He was a resident physician in Anatomic Pathology at the Lagos University Teaching Hospital, Nigeria from 1995 to 1998. He later proceeded to Dusseldorf, Germany for further training in Anatomic Pathology at the Heinrich Heine University from 1998-2000 on an international training grant award from the prestigious German Academic Exchange Program. He received a PhD degree in Anatomic Pathology from the Heinrich Heine University in 2001 after which he proceeded to the Johns Hopkins University in Baltimore for postdoctoral training in molecular imaging.
Dr. Owonikoko's research interest is majorly in lung and thyroid cancer. He is particularly focused on the identification and clinical development of biomarkers and new treatment approaches to improve the standard of care for lung and thyroid cancer patients.
Below is a listing of current federal grants for the above principal investigator.
Publications Publication Date
Dr. Owonikoko's awards and honors include:
- Michaele C. Christian Oncology Drug Development Award, National Cancer Institute, 2020
- MilliPub Club Award, Emory University School of Medicine, 2020
- Heine H. Hansen Lectureship Award, International Association for the Study of Lung Cancer, 2017
- Cancer Clinical Investigator Team Leadership Award, National Cancer Institute, 2016
- Best Poster Award, CEC Molecular and Translational Oncology Workshop, Leesburg, VA, 2008
- Oncology Institute Fellowship Training Award, AMGEN, 2007
- Chairman's Award for the Best PGY3 Resident, 2005
- Chairman's Award for the Best PGY2 Resident, 2004
- Chairman's Award for the Best PGY1 Resident, 2003